Transplantation

publication venue for

Vouchers for Future Kidney Transplants to Overcome "Chronological Incompatibility" Between Living Donors and Recipients. 2017
Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft. 2006
Fulminant hepatic failure from primary hepatic lymphoma: successful treatment with orthotopic liver transplantation and chemotherapy. 2005
Current recommendations for delaying renal transplantation after localized prostate cancer treatment: are they still appropriate? 2004
Insulin independence achieved using the transmesenteric approach to the portal vein for islet transplantation. 2004
Successful transplantation of donor organs from a hemlock poisoning victim. 2003
Liver transplantation for acute Budd-Chiari syndrome in identical twin sisters with Factor V leiden mutation. 2003
Renal allograft loss as the result of polyomavirus interstitial nephritis after simultaneous kidney-pancreas transplantation: results with kidney retransplantation. 2003
MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry with a review of published literature. 2003
Multivisceral transplantation for portal hypertension and diffuse mesenteric thrombosis caused by protein C deficiency. 2002
Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience. 2001
Renal cell carcinoma detected in a cadaveric donor after orthotopic liver and contralateral renal transplantation in two recipients: four-year follow-up. 2001
Successful reuse of portal-enteric technique in pancreas retransplantation. 2000
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. 1999
Anticardiolipin antibody-associated stroke after liver transplantation. 1997
Renal allograft thrombosis associated with the antiphospholipid antibody syndrome. 1995
Successful liver transplantation for isoniazid-induced hepatic failure--a case report. 1994
Successful reversal of hyperacute renal allograft rejection with the anti-CD3 monoclonal OKT3. 1992
Successful orthotopic liver transplantation in a child with Langerhans cell histiocytosis. 1991
Postpartum renal failure in a renal transplant patient. 1989
Percutaneous transluminal dilation in renal transplant arterial stenosis. 1980
DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. 1980
Bone marrow transplantation using typing for glyoxalase I as a tool in histocompatibility testing. 1979
Evaluation of Immunocompetence and Biomarkers of Tolerance in Chimeric and Immunosuppression-free Kidney Allograft Recipients. 2023
Another Tool in the Quest for the Perfect Living Liver Donor Operation. 2023
Vibration Controlled Transient Elastography to Evaluate Steatosis in Candidate Living Donors for Liver Transplantation. 2023
The Medawar Prize Acceptance Speech 2022.. 106. 2022
Seeking Standardized Definitions for HLA-incompatible Kidney Transplants: A Systematic Review.. 107. 2022
Pre-kidney Donation Pregnancy Complications and Long-term Outcomes.. 106. 2022
Serum MicroRNA Transcriptomics and Acute Rejection or Recurrent Hepatitis C Virus in Human Liver Allograft Recipients: A Pilot Study.. 106. 2022
BNT162b2 Vaccination Before Heart Transplantation: Kinetics of the Antibody Response.. 106. 2022
Incidence, Clinical Correlates, and Outcomes of Pulmonary Hypertension After Kidney Transplantation: Analysis of Linked US Registry and Medicare Billing Claims.. 106. 2022
FOXP3 mRNA Profile Prognostic of Acute T Cell-mediated Rejection and Human Kidney Allograft Survival.. 105. 2021
Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.. 105. 2021
Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium.. 105. 2021
Trinational Study Exploring the Early Impact of the COVID-19 Pandemic on Organ Donation and Liver Transplantation at National and Unit Levels.. 104. 2020
Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.. 104. 2020
Donor-host Lymphatic Anastomosis After Murine Lung Transplantation.. 104. 2020
Geographic Differences in Population Health and Expected Organ Supply in the Gulf Coast Region of the United States Compared to Non-Gulf States.. 104. 2020
Perceptions and Practices Regarding Frailty in Kidney Transplantation: Results of a National Survey.. 104. 2020
Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center Experience.. 104. 2020
The Hispanic Paradox in Patients With Liver Cirrhosis: Current Evidence From a Large Regional Retrospective Cohort Study.. 103. 2019
Center Variation and Risk Factors for Failure to Complete 6 Month Postdonation Follow-up Among Obese Living Kidney Donors.. 103. 2019
Deceased Brain Dead Donor Liver Transplantation and Utilization in the United States: Nighttime and Weekend Effects.. 103. 2019
International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation.. 103. 2019
Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation.. 102. 2018
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation in Children.. 102. 2018
Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.. 102. 2018
Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant.. 102. 2018
Patient and Kidney Allograft Survival in Recipients With End-Stage Renal Disease From Amyloidosis.. 102. 2018
Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up.. 102. 2018
Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study.. 102. 2018
Belatacept Compared With Tacrolimus for Kidney Transplantation: A Propensity Score Matched Cohort Study.. 101. 2017
New Dimensions in Renal Transplant Sonography: Applications of 3-Dimensional Ultrasound.. 101. 2017
Successful Posttransplant Treatment of Hepatitis C With Ledipasvir-Sofosbuvir in HIV+ Kidney Transplant Recipients.. 101. 2017
Use of HCV+ Donors Does Not Affect HCV Clearance With Directly Acting Antiviral Therapy But Shortens the Wait Time to Kidney Transplantation.. 101. 2017
A Paired Kidney Analysis of Multiorgan Transplantation: Implications for Allograft Survival.. 101. 2017
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.. 101. 2017
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.. 101. 2017
Early Readmission After Kidney Transplantation: Examination of Discharge-Level Factors.. 100. 2016
Design and Implementation of the International Genetics and Translational Research in Transplantation Network.. 99. 2015
Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease: A Multicenter Study.. 99. 2015
Recipient-matching of Passenger Leukocytes Prolongs Survival of Donor Lung Allografts in Miniature Swine.. 99. 2015
Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.. 99. 2015
Prevalence of incidental findings on abdominal computed tomography angiograms on prospective renal donors.. 99. 2015
Hepatitis C genotype influences post-liver transplant outcomes.. 99. 2015
Barriers to preemptive renal transplantation: a single center questionnaire study.. 99. 2015
Gut microbial community structure and complications after kidney transplantation: a pilot study.. 98. 2014
Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients.. 98. 2014
Liver transplantation in Latin America: the state-of-the-art and future trends.. 98. 2014
Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.. 97. 2014
Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients.. 97. 2014
Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection.. 97. 2014
Abrogation of chronic rejection in rat model system involves modulation of the mTORC1 and mTORC2 pathways.. 96. 2013
Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: a single-center report of 1166 kidney allograft recipients.. 96. 2013
Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients.. 96. 2013
Noninvasive prognostication of polyomavirus BK virus-associated nephropathy.. 96. 2013
Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.. 95. 2013
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.. 95. 2013
HIV-infected kidney graft recipients managed with an early corticosteroid withdrawal protocol: clinical outcomes and messenger RNA profiles.. 95. 2013
Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.. 95. 2013
MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis.. 94. 2012
Early corticosteroid withdrawal in recipients of renal allografts: a single-center report of ethnically diverse recipients and recipients of marginal deceased-donor kidneys.. 94. 2012
Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection.. 94. 2012
Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation.. 94. 2012
Kidneys from older living donors provide excellent intermediate-term outcomes after transplantation.. 94. 2012
Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database.. 94. 2012
Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry.. 94. 2012
Discovery and validation of a molecular signature for the noninvasive diagnosis of human renal allograft fibrosis.. 93. 2012
Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.. 93. 2012
Mean arterial blood pressure while awaiting kidney transplantation is associated with the risk of primary nonfunction.. 93. 2012
Results of repeat renal transplantation after graft loss from BK virus nephropathy.. 92. 2011
Basiliximab induction and delayed calcineurin inhibitor initiation in liver transplant recipients with renal insufficiency.. 91. 2011
Effect of immunosuppression for first kidney or kidney/pancreas transplant on sensitization at the time of second transplant.. 91. 2011
Treatment with interleukin-12/23p40 antibody attenuates acute cardiac allograft rejection.. 91. 2011
Urinary cell levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and acute rejection of human renal allografts.. 90. 2010
Diannexin decreases inflammatory cell infiltration into the islet graft, reduces β-cell apoptosis, and improves early graft function.. 90. 2010
Successful transplantation of single kidneys from pediatric donors weighing less than or equal to 10 kg into standard weight adult recipients.. 90. 2010
Factors associated with primary graft failure after heart transplantation.. 90. 2010
Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers.. 90. 2010
Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation.. 89. 2010
Effects of influenza immunization on humoral and cellular alloreactivity in humans.. 89. 2010
Comparing an early corticosteroid/late calcineurin-free immunosuppression protocol to a sirolimus-, cyclosporine A-, and prednisone-based regimen for pancreas-kidney transplantation.. 89. 2010
Impact of reduced nephron mass on cyclosporine- and/or sirolimus-induced nephrotoxicity.. 88. 2009
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.. 88. 2009
Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.. 86. 2008
Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication.. 86. 2008
Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.. 86. 2008
Carbon monoxide ameliorates renal cold ischemia-reperfusion injury with an upregulation of vascular endothelial growth factor by activation of hypoxia-inducible factor.. 85. 2008
OX40 controls islet allograft tolerance in CD154 deficient mice by regulating FOXP3+ Tregs.. 85. 2008
Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d.. 85. 2008
Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.. 85. 2008
Ipsilateral placement in double-kidney transplantation.. 84. 2007
The effect of etanercept on cardiac transplant recipients: a study of TNFalpha antagonism and cardiac allograft hypertrophy.. 84. 2007
BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes.. 84. 2007
Hyperexpression of Foxp3 and IDO during acute rejection of islet allografts.. 83. 2007
Changes in coronary arterial dimensions early after cardiac transplantation.. 83. 2007
Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.. 83. 2007
Does renal function deteriorate more rapidly in diabetic cardiac transplant recipients?. 83. 2007
Impaired arterial compliance and aerobic endurance in kidney transplant recipients.. 82. 2006
Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.. 82. 2006
Clinical utility of histological features of polyomavirus allograft nephropathy.. 82. 2006
Pancreas transplantation utilizing thymoglobulin, sirolimus, and cyclosporine.. 81. 2006
Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses.. 81. 2006
Inhibition of chronic rejection by antibody induced vascular accommodation in fully allogeneic heart allografts.. 80. 2005
Glucose stimulation of cytochrome C reduction and oxygen consumption as assessment of human islet quality.. 80. 2005
Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients.. 80. 2005
Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets.. 79. 2005
Methoxyethyl-modified intercellular adhesion molecule-1 antisense phosphorothiateoligonucleotides inhibit allograft rejection, ischemic-reperfusion injury, and cyclosporine-induced nephrotoxicity.. 79. 2005
Experience with 274 cardiac transplant recipients with posttransplant lymphoproliferative disorder: a report from the Israel Penn International Transplant Tumor Registry.. 78. 2004
A truncated-dose regimen of daclizumab for prevention of acute rejection in kidney transplant recipients: a single-center experience.. 78. 2004
The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function.. 78. 2004
Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection.. 77. 2004
Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation.. 77. 2004
Preservation of human pancreatic islet in vivo function after 6-month culture in serum-free media.. 77. 2004
Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results.. 77. 2004
Pulsatile machine perfusion with Vasosol solution improves early graft function after cadaveric renal transplantation.. 77. 2004
Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center.. 77. 2004
Right laparoscopic live donor nephrectomy: a single institution experience.. 77. 2004
Toll-like receptor-4 and allograft responses.. 77. 2004
Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.. 76. 2003
Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression.. 76. 2003
Adenovirus infection in pediatric small bowel transplantation recipients.. 76. 2003
Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation.. 75. 2003
Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection.. 75. 2003
Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts.. 75. 2003
CD103 mRNA levels in urinary cells predict acute rejection of renal allografts.. 75. 2003
Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation.. 75. 2003
Administration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients.. 75. 2003
Posttransplant administration of allochimeric major histocompatibility complex class-I-molecules induces true transplantation tolerance.. 75. 2003
Proapoptotic Bax is hyperexpressed in isolated human islets compared with antiapoptotic Bcl-2.. 74. 2002
Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis.. 74. 2002
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine.. 74. 2002
Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function.. 74. 2002
Quantitative detection of T-cell activation markers by real-time PCR in renal transplant rejection and correlation with histopathologic evaluation.. 74. 2002
Enforced c-REL deficiency prolongs survival of islet allografts1.. 74. 2002
Investigation of promoter polymorphisms in the tumor necrosis factor-alpha and interleukin-10 genes in liver transplant patients.. 73. 2002
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy.. 73. 2002
Early graft function after pediatric liver transplantation: comparison between in situ split liver grafts and living-related liver grafts.. 72. 2001
Improved in vivo pancreatic islet function after prolonged in vitro islet culture.. 72. 2001
Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients.. 72. 2001
Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection.. 72. 2001
Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation.. 72. 2001
The influence of acute rejection on long-term renal allograft survival: a comparison of living and cadaveric donor transplantation.. 72. 2001
The effect of gut metabolism on tacrolimus bioavailability in renal transplant recipients.. 71. 2001
Interleukin-2 and interferon-gamma double knockout mice reject heterotopic cardiac allografts.. 70. 2000
Rapamycin induces transforming growth factor-beta production by lymphocytes.. 70. 2000
Inhibition of C-raf expression by antisense oligonucleotides extends heart allograft survival in rats.. 70. 2000
Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.. 70. 2000
Glutathione supplementation during cold ischemia does not confer early functional advantage in renal transplantation.. 70. 2000
Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity.. 69. 2000
The influence of pulsatile preservation on renal transplantation in the 1990s.. 69. 2000
Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function.. 69. 2000
Simultaneous kidney-pancreas transplantation without antilymphocyte induction.. 69. 2000
Tuberculosis in orthotopic liver transplant patients: increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.. 69. 2000
Changes in patterns of 24-hr heart rate variability after kidney and kidney-pancreas transplant.. 68. 1999
Glucose control and long-term survival in biobreeding/Worcester rats after intraperitoneal implantation of hydrophilic macrobeads containing porcine islets without immunosuppression.. 68. 1999
The probability of HLA-C matching between patient and unrelated donor at the molecular level: estimations based on the linkage disequilibrium between DNA typed HLA-B and HLA-C alleles.. 68. 1999
Perfusion of kidneys with unformulated "naked" intercellular adhesion molecule-1 antisense oligodeoxynucleotides prevents ischemic/reperfusion injury.. 68. 1999
The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery.. 67. 1999
The United States liver donor population in the 1990s: a descriptive, population-based comparative study.. 67. 1999
A simple model to estimate survival after retransplantation of the liver.. 67. 1999
Strategies to expand the donor pool for pancreas transplantation.. 67. 1999
Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment.. 66. 1998
Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejection.. 66. 1998
Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.. 66. 1998
Utility of adenoviral-mediated Fas ligand gene transfer to modulate islet allograft survival.. 66. 1998
Differential expression of T-cell growth factors in rejecting murine islet and human renal allografts: conspicuous absence of interleukin (IL)-9 despite expression of IL-2, IL-4, IL-7, and IL-15.. 66. 1998
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.. 66. 1998
A comparison of media supplement methods for the extended culture of human islet tissue.. 65. 1998
Liver transplantation for decompensated cirrhosis after jejunoileal bypass: a strategy for management.. 65. 1998
In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.. 65. 1998
Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference.. 65. 1998
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study.. 65. 1998
Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation.. 64. 1997
Cold ischemic injury accelerates the progression to chronic rejection in a rat cardiac allograft model.. 64. 1997
In situ splitting of the cadaveric liver for transplantation.. 64. 1997
In vivo hyperexpression of transforming growth factor-beta1 in mice: stimulation by cyclosporine.. 63. 1997
Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors.. 63. 1997
Cyclosporine reduces development of obliterative bronchiolitis in a murine heterotopic airway model.. 63. 1997
Allogeneic transplantation for advanced leukemia: improved short-term outcome with blood stem cell grafts and tacrolimus.. 62. 1996
Molecular executors of cell death--differential intrarenal expression of Fas ligand, Fas, granzyme B, and perforin during acute and/or chronic rejection of human renal allografts.. 62. 1996
Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation.. 62. 1996
Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles.. 62. 1996
Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.. 62. 1996
Induction of transplantation tolerance by chimeric donor/recipient class I RT1.Aa molecules.. 62. 1996
Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution.. 62. 1996
CD2 antigen targeting reduces intragraft expression of mRNA-encoding granzyme B and IL-10 and induces tolerance.. 62. 1996
The correlation of Banff scoring with reversibility of first and recurrent rejection episodes.. 61. 1996
Clinical observations of metabolic changes occurring in renal transplant recipients receiving ketoconazole.. 61. 1996
Incidence and significance of Aspergillus cultures following liver and kidney transplantation.. 61. 1996
Long-term preservation of islets of Langerhans in hydrophilic macrobeads.. 61. 1996
Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice.. 61. 1996
Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition.. 60. 1995
Mycobacterium haemophilum infections in bone marrow transplant recipients.. 60. 1995
Membrane-bound or soluble truncated RT1.Aa rat class I major histocompatibility antigens induce specific alloimmunity.. 60. 1995
Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts.. 60. 1995
Allogeneic lymphocyte proliferation stimulated by small intestine-derived epithelial cells.. 60. 1995
An analysis of renal function in pancreas-kidney and diabetic kidney-alone recipients at two years following transplantation.. 59. 1995
Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.. 59. 1995
Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients.. 59. 1995
Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Immunosuppression with TGF-beta 1 or vIL-10.. 59. 1995
Retrievable, replaceable, macroencapsulated pancreatic islet xenografts. Long-term engraftment without immunosuppression.. 59. 1995
Abdominal multivisceral transplantation.. 59. 1995
Pathogenesis of obliterative bronchiolitis. Possible roles of platelet-derived growth factor and basic fibroblast growth factor.. 59. 1995
CTLA4Ig prolongs allograft survival while suppressing cell-mediated immunity.. 58. 1994
Rapamycin, cyclosporine, and perioperative donor-specific transfusions induce prolongation of cardiac allograft survival in the rat.. 58. 1994
Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human alpha/beta-T cell receptor.. 57. 1994
Synergistic immunosuppressive actions of cyclosporine with a mouse anti-rat alpha/beta-T cell receptor monoclonal antibody.. 57. 1994
The relationship of glucose disappearance rate (kG) to acute pancreas allograft rejection.. 57. 1994
Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life.. 57. 1994
Small intestinal transplantation in humans with or without the colon.. 57. 1994
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.. 57. 1994
Regulation of new DNA synthesis in mammalian cells by cyclosporine. Demonstration of a transforming growth factor beta-dependent mechanism of inhibition of cell growth.. 57. 1994
Parvovirus B19 infection in pediatric transplant patients.. 56. 1993
Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients.. 56. 1993
The effect of donor-recipient strain combination on rejection and graft-versus-host disease after small bowel/liver transplantation in the rat.. 56. 1993
Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.. 55. 1993
Synergism between the CD3 antigen- and CD2 antigen-derived signals. Exploration at the level of induction of DNA-binding proteins and characterization of the inhibitory activity of cyclosporine.. 55. 1993
Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.. 55. 1993
Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model.. 55. 1993
The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.. 55. 1993
Characterization of maturation and function of natural killer cells in xenogeneic (rat-->mouse) bone marrow chimeras. Evidence that rat NK cells are present and functional in a xenogeneic environment.. 55. 1993
One-year monkey heart xenograft survival in cyclosporine-treated baboons. Suppression of the xenoantibody response with total-lymphoid irradiation.. 54. 1992
Percutaneous biopsy of pancreas transplants.. 54. 1992
Myocardial energy metabolism in asphyxiated canine hearts preserved for 24 hours.. 53. 1992
Prediction by postrevascularization biopsies of cadaveric kidney allografts of rejection, graft loss, and preservation nephropathy.. 53. 1992
Correlation between percutaneous renal biopsy and the indium-111-labeled platelet scan in diagnosing acute renal allograft rejection.. 53. 1992
Mixed xenogeneic chimeras (rat + mouse to mouse). Evidence of rat stem cell engraftment, strain-specific transplantation tolerance, and skin-specific antigens.. 53. 1992
Enisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group.. 53. 1992
The ability of pretransplant test-dose pharmacokinetic profiles to reduce early adverse events after renal transplantation.. 53. 1992
Cytomegalovirus infection of renal allografts. Detection by polymerase chain reaction.. 53. 1992
Inhibition of interleukin 2 receptor expression in normal human T cells by cyclosporine. Demonstration at the mRNA, protein, and functional levels.. 53. 1992
Treatment of hyperlipidemia in renal transplant patients with gemfibrozil and dietary modification.. 53. 1992
Beta-adrenergic receptor sensitivity and guanine nucleotide regulatory proteins in transplanted human hearts and autotransplanted baboons.. 52. 1991
Combined small bowel and liver transplantation in the rat: possible role of the liver in preventing intestinal allograft rejection.. 52. 1991
Effects of in vivo treatment with FK506 on natural killer cells in rats.. 51. 1991
Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation.. 51. 1991
Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapy.. 51. 1991
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.. 51. 1991
The molecular basis for the synergism between the CD3/alpha beta T cell receptor and the CD2 antigen-derived signals in promoting T-cell proliferation.. 51. 1991
Characterization of the interstitial cellular infiltrate in experimental chronic cyclosporine nephropathy.. 49. 1990
Possible association of the immunosuppressive and B cell lymphoma-promoting properties of cyclosporine.. 49. 1990
Lack of effect of oxygen-radical scavenging systems in the preserved reperfused rabbit kidney.. 48. 1989
Lung biopsy evaluation of acute rejection versus opportunistic infection in lung transplant patients.. 47. 1989
Transmembrane signalling via the T cell antigen receptor heterodimer and the CD2 antigen. A synergistic pathway for activation of T cells.. 47. 1989
Selective depletion of Kupffer cells in mice by intact ricin.. 47. 1989
The effects of cooling rates and storage temperature on the function of 24-hour cold-preserved rabbit kidneys.. 46. 1988
The mechanism of discordant xenograft rejection.. 46. 1988
Chronic cyclosporine nephrotoxicity. A rodent model.. 46. 1988
Human memory T cell activation. Effects of monoclonal antibodies directed at interleukin-2, receptors for interleukin-2, or interferon-gamma.. 46. 1988
Use of anti-L3T4 and anti-Ia treatments for prolongation of xenogeneic islet transplants.. 46. 1988
Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo.. 45. 1988
Small bowel transplantation in the rat. Effect of pretransplant blood transfusions and cyclosporine on host survival.. 45. 1988
In vivo effects of high-dose steroids on nucleic acid content of immunocompetent cells of renal allograft recipients.. 45. 1988
Differentiation of presumed sepsis from acute graft-versus-host disease by C-reactive protein and serum total IgE in bone marrow transplant recipients.. 44. 1987
The effect of verapamil on cellular uptake, organ distribution, and pharmacology of cyclosporine.. 44. 1987
HLA-A2 in sarcomas: an immunobiologic perspective.. 43. 1987
OKT3 treatment of steroid-resistant renal allograft rejection.. 43. 1987
Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding protein.. 41. 1986
Induction of graft-versus-host disease by small intestinal allotransplantation in rats.. 40. 1985
Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay.. 40. 1985
Alterations in the generalized Shwartzman reaction induced by cyclosporine.. 40. 1985
A reappraisal of the effects of monoclonal antibodies directed at T cell differentiation antigens.. 38. 1984
Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.. 38. 1984
Long-term renal allograft survival in rats preimmunized with donor strain RT1.B antigens.. 35. 1983
Abrogation of proliferation and generation of cytotoxic T cells in human mixed lymphocyte culture reactions by modification of the cell surface with mitogenic oxidizing agents.. 34. 1982
Enhanced kidney graft survival with retroplacental source gamma-globulin. Results of a 5-year prospective study at a single center.. 33. 1982
Immunosuppressive properties of polar organic compounds that induce cellular differentiation in Friend erythroleukemia cells.. 33. 1982
Impact of hepatitis on renal transplantation.. 32. 1981
Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.. 32. 1981
Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents.. 30. 1980
Effects of protein-calorie restriction on the immune response to skin allografts in the rat.. 30. 1980
Transplantation tolerance across major histocompatibility barriers after total lymphoid irradiation.. 28. 1979
Differential antibody responses to Ag-B (A region) and Ia (B region) antigens during enhancement of rat renal allografts.. 28. 1979
Adverse presensitization to renal transplants. Detection by utilization of a D locus antigen-defined lymphoblastoid cell panel as targets in antibody-dependent cell-mediated cytotoxicity assays.. 27. 1979
Cryopreservation of human effector cells active in antibody-dependent cell-mediated cytotoxicity.. 21. 1976
Chimerism detected by HL-A typing.. 15. 1973
Trypsinization of lymphocytes for HL-A typing.. 13. 1972
Retraction.. 79. 2005
The Delicate Balance Between Donors and Recipients. 2021
Cystatin C: The Answer or a Call for Better Kidney Biomarkers in Cirrhosis? 2020
Active Education, Keeping It Personal and Making It Easy: A Potential Path to Increasing Donors. 2015
Financial and social complications as barriers to satisfaction with life among living kidney donors. 2014
Pretransplant genetic testing of live kidney donors at risk for autosomal dominant polycystic kidney disease. 2009
Noninvasive imaging of living kidney donors. 2008
Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients. 2022
Safety, Effectiveness, and Tolerability of Patiromer in Kidney Transplant Recipients. 2019
Adherence to hepatitis B immunoglobulin (HBIG) after liver transplantation. 2013
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy. 2013
High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection. 2013
On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. 2013
Malakoplakia-induced diarrhea in a kidney transplant recipient. 2010
Sirolimus (rapamycin) induced proteinuria in a patient undergoing allogeneic hematopoietic stem cell transplant. 2008
Ipsilateral placement in double-kidney transplantation: an old technique in a new fashion. 2008
Impact of sirolimus on early graft function after deceased-donor kidney transplantation. 2005
Mycophenolate mofetil is compatible with CD28/CD154 costimulatory blockade in preventing transplant rejection. 2005
Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK VP1 virus in urine. 2003
Transbronchial biopsy. 1990
Proceedings of the 2006 World Transplant Congress, Boston, Massachusetts, USA. 2006
Biomarkers for Chronic Rejection: In Angiotensin Proteins We Trust?. 103. 2019
New Tricks for Leukocytes: Memory Where You Least Suspect It.. 99. 2015
The Nobel Prize-winning work of Ralph Steinman (1943-2011) and its relevance to transplantation.. 95. 2013
Transplantation: a report of progress.. 95. 2013
Transplantation: a report of progress.. 90. 2010
The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance.. 90. 2010
Transplantation: a report of progress.. 86. 2008
Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation. 2020
A Comprehensive Review of Outcome Predictors in Low MELD Patients. 2020
HCV Antiviral Therapy in Liver Transplant Candidates and Recipients With Renal Insufficiency. 2017
The Emerging Role of Nanotechnology in Cell and Organ Transplantation. 2016
Novel Hepatitis C Treatment and the Impact on Kidney Transplantation. 2015
The Evolving Roles of Memory Immune Cells in Transplantation. 2015
Pericytes, microvasular dysfunction, and chronic rejection. 2015
MicroRNAs: small RNAs with big effects. 2010
Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. 2008
STAT3: an important regulator of multiple cytokine functions. 2008
The role of mast cells after solid organ transplantation. 2008
Why nondocumented residents should have access to kidney transplantation: arguments for lifting the federal ban on reimbursement. 2007
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. 2005
Tolerance and chimerism. 2003
FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. 1999
Mycobacterium tuberculosis infection of a native polycystic kidney following renal transplantation. 1998

VIVO Weill Cornell Medical College

Transplantation Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)